Sabine Mueller

2.7k total citations
46 papers, 695 citations indexed

About

Sabine Mueller is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Sabine Mueller has authored 46 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 17 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Sabine Mueller's work include Glioma Diagnosis and Treatment (28 papers), Neuroblastoma Research and Treatments (13 papers) and Melanoma and MAPK Pathways (5 papers). Sabine Mueller is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Neuroblastoma Research and Treatments (13 papers) and Melanoma and MAPK Pathways (5 papers). Sabine Mueller collaborates with scholars based in United States, Germany and Netherlands. Sabine Mueller's co-authors include Daphne A. Haas‐Kogan, William A. Weiss, Pratiti Bandopadhayay, Steven G. DuBois, Bertram Nickolay, Michael D. Prados, Kevin X. Liu, Mitchel S. Berger, Xiaodong Yang and Katherine K. Matthay and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Sabine Mueller

40 papers receiving 684 citations

Peers

Countries citing papers authored by Sabine Mueller

Since Specialization

Citations

This map shows the geographic impact of Sabine Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Mueller more than expected).

Fields of papers citing papers by Sabine Mueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Mueller. The network helps show where Sabine Mueller may publish in the future.

Co-authorship network of co-authors of Sabine Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Mueller. A scholar is included among the top collaborators of Sabine Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Mueller. Sabine Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics 2025 ·Neuro-Oncology Advances ·Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R. Gilbert, Cynthia Hawkins, Juergen Hench, Thomas S. Jacques, David Jones, David N. Louis, Sabine Mueller, Brent A. Orr, MacLean P. Nasrallah, Stefan M. Pfister, Felix Sahm, Matija Snuderl, David A. Solomon, Pascale Varlet, Pieter Wesseling	9
2	LGG-15. DEEP LEARNING ENABLES LONGITUDINAL RISK PREDICTION FOR PEDIATRIC LOW-GRADE GLIOMAS AFTER SURGERY 2024 ·Neuro-Oncology ·(unknown), (unknown), (unknown), Zezhong Ye, Sridhar Vajapeyam, (unknown), (unknown), Ariana Familiar, Kevin Liu, Pratiti Bandopadhayay, Ali Nabavizadeh, Sabine Mueller, Hugo J.W.L. Aerts, Daphne A. Haas‐Kogan, Tina Young Poussaint, Benjamin H. Kann	1
3	ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma 2024 ·Neuro-Oncology ·Isabel Arrillaga‐Romany, Andrew B. Lassman, Susan L. McGovern, Sabine Mueller, Burt Nabors, Martin J. van den Bent, Michael A. Vogelbaum, Joshua E. Allen, Allen S. Melemed, Rohinton S. Tarapore, Patrick Y. Wen, Timothy F. Cloughesy	25
4	Omnigene-Guttm ensures fecal microbiome stability in the pediatric population 2024 ·AMB Express ·(unknown), (unknown), Hyun-ju Lee, Sabine Mueller, Cassie Kline, John Bianco, Janetta Top, Marcel R. de Zoete, Lennart Kester, Friso Calkoen, Jasper van der Lugt	0
5	Diffusion deep learning for brain age prediction and longitudinal tracking in children through adulthood 2024 ·Imaging Neuroscience ·(unknown), (unknown), Zezhong Ye, Kevin X. Liu, Jirapat Likitlersuang, Sridhar Vajapeyam, (unknown), Jakob Seidlitz, Richard A. I. Bethlehem, Raymond H. Mak, Sabine Mueller, Daphne A. Haas‐Kogan, Tina Young Poussaint, Hugo J.W.L. Aerts, Benjamin H. Kann	1
6	Type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma (pLGG): Reversible decreases in growth velocity in the phase 2 FIREFLY-1 trial. 2024 ·Journal of Clinical Oncology ·Cassie Kline, Angela J. Waanders, David S. Ziegler, Lindsay Kilburn, Karsten Nysom, Jasper van der Lugt, Tim Hassall, Nicolas U. Gerber, Devorah Segal, (unknown), Sabine Mueller, Ashley A. Walter, Peter Manley, Lisa McLeod, Daniel Landi	2
7	LGG-05. IMAGING-BASED DEEP LEARNING FOR EVENT-FREE SURVIVAL PREDICTION IN PATIENTS WITH PEDIATRIC LOW-GRADE GLIOMA 2023 ·Neuro-Oncology ·(unknown), (unknown), Zezhong Ye, Sridhar Vajapeyam, (unknown), (unknown), Kevin X. Liu, Hugo J.W.L. Aerts, Pratiti Bandopadhayay, Daphne A. Haas‐Kogan, (unknown), Adam Resnick, Sabine Mueller, Tina Young Poussaint, Tabitha Cooney, Benjamin H. Kann	1
8	P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA 2023 ·Neuro-Oncology ·Isabel Arrillaga‐Romany, Andrew B. Lassman, Susan L. McGovern, Sabine Mueller, Burt Nabors, Martin J. van den Bent, Michael A. Vogelbaum, (unknown), Allen S. Melemed, Rohinton S. Tarapore, Patrick Y. Wen, (unknown)	0
9	Pediatric low-grade glioma: State-of-the-art and ongoing challenges 2023 ·Neuro-Oncology ·Jason Fangusaro, David Jones, Roger J. Packer, David H. Gutmann, Till Milde, Olaf Witt, Sabine Mueller, Michael J. Fisher, Jordan R. Hansford, Uri Tabori, Darren Hargrave, Pratiti Bandopadhayay	33
10	CTIM-11. MRNA AGGREGATES ELICIT RAPID IMMUNOLOGIC RESPONSE AND PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS 2023 ·Neuro-Oncology ·Ashley Ghiaseddin, (unknown), Maryam Rahman, (unknown), Dingpeng Zhang, Chong Zhao, (unknown), Jesse Kresak, (unknown), Sebastián Gatica, John A. Ligon, Paul Castillo, Jianping Huang, Natalie L. Silver, Eugene Hwang, Cassie Kline, Sabine Mueller, Michael D. Prados, Duane A. Mitchell, Elias Sayour	2
11	Review: Neurological Complications From Therapies for Pediatric Brain Tumors 2022 ·Frontiers in Oncology ·Thien Nguyen, Sabine Mueller, Fatema Malbari	7
12	CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS 2022 ·Neuro-Oncology ·Karen Wright, Cassie Kline, Mohamed S Abdelbaki, (unknown), Elias Sayour, Jennifer Elster, Sarah Leary, Matthew A. Miller, Ashley Margol, Kenneth J. Cohen, Lindsay Kilburn, Anne Bendel, Pei‐Chi Kao, Clement Ma, Wendy B. London, Sabine Mueller, Michael D. Prados, Daphne A. Haas‐Kogan	9
13	Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas 2018 ·Cancer Research ·Sharmistha Pal, David Kozono, Xiaodong Yang, Wojciech Fendler, (unknown), Jing Ni, John A. Alberta, Jean J. Zhao, Kevin X. Liu, Jie Bian, Nathalène Truffaux, William A. Weiss, Adam Resnick, Pratiti Bandopadhayay, Keith L. Ligon, Steven G. DuBois, Sabine Mueller, Dipanjan Chowdhury, Daphne A. Haas‐Kogan	71
14	BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas 2016 ·Clinical Cancer Research ·Aleksandra Olow, Sabine Mueller, Xiao-Dong Yang, Rintaro Hashizume, Justin Meyerowitz, William A. Weiss, Adam Resnick, Angela J. Waanders, Lukas J.A. Stalpers, Mitchel S. Berger, Nalin Gupta, C. David James, Claudia Petritsch, Daphne A. Haas‐Kogan	33
15	Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma 2015 ·Journal of Neuro-Oncology ·Tina Dasgupta, Aleksandra Olow, Xiao-Dong Yang, Rintaro Hashizume, Theodore Nicolaides, Maxwell W. Tom, (unknown), Mitchel S. Berger, William A. Weiss, Lukas J.A. Stalpers, Michael D. Prados, C. David James, Sabine Mueller, Daphne A. Haas‐Kogan	31
16	Multidisciplinary Care of Patients with Brain Tumors 2013 ·Surgical Oncology Clinics of North America ·(unknown), Sabine Mueller, Martin J. Rutkowski, Seunggu J. Han, Orin Bloch, Igor J. Barani, Andrew T. Parsa, Susan M. Chang	6
17	Risk of First and Recurrent Stroke in Childhood Cancer Survivors Treated With Cranial and Cervical Radiation Therapy 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Sabine Mueller, Katherine Sear, Nancy K. Hills, (unknown), Shervin Afghani, (unknown), Daphne A. Haas‐Kogan, Heather J. Fullerton	46
18	PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome 2012 ·Neuro-Oncology ·Sabine Mueller, Joanna J. Phillips, Arzu Onar‐Thomas, Eduardo Romero, Shichun Zheng, John K. Wiencke, Sean M. McBride, (unknown), Michael D. Prados, William A. Weiss, Mitchel S. Berger, Nalin Gupta, Igor Yu. Kogan	76
19	Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems 2011 ·Clinical Cancer Research ·Swati S. More, Melissa Itsara, Xiao-Dong Yang, Ethan G. Geier, (unknown), Youngho Seo, Henry F. VanBrocklin, William A. Weiss, Sabine Mueller, Daphne A. Haas‐Kogan, Steven G. DuBois, Katherine K. Matthay, Kathleen M. Giacomini	51
20	Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms 2011 ·Cancer Letters ·Sabine Mueller, Xiaodong Yang, Theo Sottero, (unknown), Gautam Prasad, Mei‐Yin C. Polley, William A. Weiss, Katherine K. Matthay, Andrew M. Davidoff, Steven G. DuBois, Daphne A. Haas-Kogan	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact